etoposide_HL60_UP
GeneID | Mean_1 | Mean_2 | StDev_1 | StDev_2 | T-Statistic | p-value | Symbol | Description | |
---|---|---|---|---|---|---|---|---|---|
1 | 5743 | 2.3 | 2.3 | 0.0 | 0.1 | 0.343 | 0.7562 | PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
2 | 5742 | 3.8 | 2.5 | 0.5 | 0.4 | -3.394 | 0.0283 | PTGS1 | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
3 | 3725 | 9.2 | 10.3 | 0.7 | 0.3 | 2.573 | 0.0962 | JUN | jun proto-oncogene |
4 | 57103 | 4.8 | 7.1 | 0.5 | 0.3 | 6.585 | 0.0075 | C12orf5 | chromosome 12 open reading frame 5 |
5 | 11009 | 2.6 | 9.5 | 0.1 | 2.0 | 5.960 | 0.0266 | IL24 | interleukin 24 |
6 | 9935 | 8.0 | 10.2 | 0.5 | 0.3 | 6.729 | 0.0056 | MAFB | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B |
7 | 23764 | 4.1 | 5.1 | 0.8 | 0.2 | 2.247 | 0.1414 | MAFF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
8 | 4938 | 2.5 | 8.0 | 0.3 | 1.3 | 6.921 | 0.0167 | OAS1 | 2'-5'-oligoadenylate synthetase 1, 40/46kDa |
9 | 3624 | 2.8 | 2.6 | 0.5 | 0.1 | -0.783 | 0.5063 | INHBA | inhibin, beta A |
10 | 4082 | 10.6 | 12.2 | 0.1 | 0.4 | 6.391 | 0.0170 | MARCKS | myristoylated alanine-rich protein kinase C substrate |
11 | 5971 | 9.1 | 9.9 | 1.0 | 0.5 | 1.289 | 0.2869 | RELB | v-rel avian reticuloendotheliosis viral oncogene homolog B |
12 | 8544 | 11.3 | 12.3 | 0.1 | 0.3 | 5.153 | 0.0167 | PIR | pirin (iron-binding nuclear protein) |
13 | 1649 | 9.2 | 11.1 | 1.2 | 1.7 | 1.642 | 0.1826 | DDIT3 | DNA-damage-inducible transcript 3 |
14 | 6648 | 11.0 | 11.2 | 0.1 | 0.4 | 1.037 | 0.4037 | SOD2 | superoxide dismutase 2, mitochondrial |
15 | 2357 | 3.9 | 3.5 | 0.4 | 1.0 | -0.665 | 0.5592 | FPR1 | formyl peptide receptor 1 |
16 | 10346 | 3.0 | 2.6 | 0.9 | 0.6 | -0.503 | 0.6453 | TRIM22 | tripartite motif containing 22 |
17 | 2920 | 2.4 | 2.7 | 0.2 | 0.2 | 1.938 | 0.1247 | CXCL2 | chemokine (C-X-C motif) ligand 2 |
18 | 3576 | 2.3 | 2.2 | 0.0 | 0.0 | -1.311 | 0.2687 | CXCL8 | chemokine (C-X-C motif) ligand 8 |
19 | 2180 | 8.7 | 10.1 | 0.0 | 0.2 | 13.094 | 0.0034 | ACSL1 | acyl-CoA synthetase long-chain family member 1 |
20 | 7980 | 7.0 | 6.2 | 0.3 | 1.0 | -1.262 | 0.3178 | TFPI2 | tissue factor pathway inhibitor 2 |
21 | 1540 | 5.9 | 6.5 | 0.3 | 0.5 | 1.819 | 0.1643 | CYLD | cylindromatosis (turban tumor syndrome) |
22 | 11182 | 11.2 | 10.2 | 0.2 | 0.5 | -2.944 | 0.0732 | SLC2A6 | solute carrier family 2 (facilitated glucose transporter), member 6 |
23 | 414062 | 3.2 | 2.9 | 0.9 | 0.2 | -0.463 | 0.6843 | CCL3L3 | chemokine (C-C motif) ligand 3-like 3 |
24 | 6347 | 2.4 | 2.2 | 0.3 | 0.0 | -1.115 | 0.3804 | CCL2 | chemokine (C-C motif) ligand 2 |
25 | 6348 | 2.3 | 3.9 | 0.0 | 1.9 | 1.509 | 0.2703 | CCL3 | chemokine (C-C motif) ligand 3 |
26 | 3587 | 5.3 | 2.6 | 1.0 | 0.3 | -4.678 | 0.0289 | IL10RA | interleukin 10 receptor, alpha |
27 | 6352 | 6.7 | 8.2 | 0.5 | 1.4 | 1.795 | 0.1867 | CCL5 | chemokine (C-C motif) ligand 5 |
28 | 8543 | 10.2 | 10.1 | 0.1 | 0.5 | -0.369 | 0.7452 | LMO4 | LIM domain only 4 |
29 | 1026 | 6.4 | 6.9 | 0.4 | 0.4 | 1.405 | 0.2338 | CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
30 | 4792 | 13.7 | 13.4 | 0.5 | 0.2 | -0.924 | 0.4295 | NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
31 | 4600 | 5.2 | 5.4 | 0.2 | 0.8 | 0.476 | 0.6765 | MX2 | MX dynamin-like GTPase 2 |
32 | 6016 | 8.6 | 8.3 | 0.3 | 0.2 | -1.449 | 0.2356 | RIT1 | Ras-like without CAAX 1 |
33 | 4599 | 8.0 | 8.7 | 0.2 | 0.3 | 3.072 | 0.0484 | MX1 | MX dynamin-like GTPase 1 |
34 | 22822 | 4.4 | 3.3 | 0.1 | 0.2 | -7.377 | 0.0059 | PHLDA1 | pleckstrin homology-like domain, family A, member 1 |
35 | 3434 | 8.9 | 14.1 | 0.7 | 1.1 | 6.761 | 0.0043 | IFIT1 | interferon-induced protein with tetratricopeptide repeats 1 |
36 | 7262 | 10.7 | 12.5 | 0.5 | 0.5 | 4.255 | 0.0131 | PHLDA2 | pleckstrin homology-like domain, family A, member 2 |
37 | 23586 | 6.6 | 8.0 | 0.2 | 0.3 | 6.593 | 0.0037 | DDX58 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 |
38 | 9134 | 7.6 | 6.1 | 0.3 | 1.7 | -1.469 | 0.2731 | CCNE2 | cyclin E2 |
39 | 1958 | 8.9 | 7.9 | 0.7 | 0.1 | -2.652 | 0.1148 | EGR1 | early growth response 1 |
40 | 56650 | 11.1 | 11.0 | 0.1 | 0.2 | -1.116 | 0.3498 | CLDND1 | claudin domain containing 1 |
41 | 25797 | 7.5 | 6.6 | 0.2 | 0.4 | -3.269 | 0.0491 | QPCT | glutaminyl-peptide cyclotransferase |
42 | 7057 | 8.2 | 9.5 | 0.1 | 0.2 | 8.524 | 0.0069 | THBS1 | thrombospondin 1 |
43 | 9636 | 13.4 | 16.6 | 0.2 | 1.1 | 5.005 | 0.0328 | ISG15 | ISG15 ubiquitin-like modifier |
44 | 6364 | 2.9 | 2.4 | 0.6 | 0.0 | -1.466 | 0.2802 | CCL20 | chemokine (C-C motif) ligand 20 |
45 | 81631 | 10.6 | 11.4 | 0.1 | 0.8 | 1.634 | 0.2390 | MAP1LC3B | microtubule-associated protein 1 light chain 3 beta |
46 | 2634 | 5.8 | 5.5 | 0.1 | 0.2 | -2.476 | 0.0806 | GBP2 | guanylate binding protein 2, interferon-inducible |
47 | 8843 | 7.7 | 5.0 | 0.1 | 1.7 | -2.735 | 0.1099 | HCAR3 | hydroxycarboxylic acid receptor 3 |
48 | 8344 | 8.8 | 9.9 | 0.2 | 0.3 | 5.938 | 0.0085 | HIST1H2BE | histone cluster 1, H2be |
49 | 8343 | 8.9 | 9.8 | 0.2 | 0.1 | 7.649 | 0.0092 | HIST1H2BF | histone cluster 1, H2bf |
50 | 8339 | 10.0 | 10.4 | 0.1 | 0.1 | 6.734 | 0.0026 | HIST1H2BG | histone cluster 1, H2bg |
51 | 10614 | 7.6 | 7.6 | 0.1 | 0.6 | -0.113 | 0.9200 | HEXIM1 | hexamethylene bis-acetamide inducible 1 |
52 | 8347 | 9.9 | 10.3 | 0.1 | 0.1 | 5.381 | 0.0101 | HIST1H2BC | histone cluster 1, H2bc |
53 | 3055 | 2.7 | 2.7 | 0.4 | 0.4 | -0.107 | 0.9196 | HCK | HCK proto-oncogene, Src family tyrosine kinase |
54 | 29940 | 8.6 | 8.3 | 0.1 | 0.4 | -1.507 | 0.2461 | DSE | dermatan sulfate epimerase |
55 | 8345 | 13.0 | 13.3 | 0.1 | 0.2 | 2.424 | 0.0836 | HIST1H2BH | histone cluster 1, H2bh |
56 | 8346 | 11.8 | 12.1 | 0.2 | 0.2 | 1.530 | 0.2108 | HIST1H2BI | histone cluster 1, H2bi |
57 | 3017 | 11.5 | 11.4 | 0.1 | 0.2 | -0.284 | 0.7991 | HIST1H2BD | histone cluster 1, H2bd |
58 | 3665 | 11.1 | 14.1 | 0.2 | 0.1 | 22.880 | 0.0000 | IRF7 | interferon regulatory factor 7 |
59 | 6772 | 8.8 | 11.6 | 0.2 | 0.2 | 16.501 | 0.0002 | STAT1 | signal transducer and activator of transcription 1, 91kDa |
60 | 5359 | 8.7 | 10.2 | 0.2 | 0.3 | 6.649 | 0.0049 | PLSCR1 | phospholipid scramblase 1 |
61 | 10379 | 7.2 | 9.9 | 0.4 | 0.2 | 11.024 | 0.0012 | IRF9 | interferon regulatory factor 9 |
62 | 2643 | 8.0 | 8.3 | 0.0 | 0.4 | 0.827 | 0.4945 | GCH1 | GTP cyclohydrolase 1 |
63 | 6385 | 11.6 | 12.0 | 0.4 | 0.1 | 1.698 | 0.2108 | SDC4 | syndecan 4 |
64 | 7128 | 2.8 | 4.6 | 0.8 | 0.7 | 2.943 | 0.0434 | TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 |
65 | 7127 | 9.0 | 6.7 | 1.1 | 1.3 | -2.208 | 0.0929 | TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 |
66 | 929 | 5.5 | 5.5 | 0.2 | 0.7 | -0.018 | 0.9869 | CD14 | CD14 molecule |
67 | 100129518 | 4.9 | 4.5 | 0.4 | 0.4 | -1.358 | 0.2464 | LOC100129518 | uncharacterized LOC100129518 |
68 | 9404 | 6.3 | 6.7 | 0.1 | 0.9 | 0.844 | 0.4854 | LPXN | leupaxin |
69 | 25976 | 7.1 | 7.0 | 0.3 | 0.1 | -0.145 | 0.8951 | TIPARP | TCDD-inducible poly(ADP-ribose) polymerase |
70 | 11259 | 4.3 | 3.7 | 0.2 | 0.5 | -1.948 | 0.1631 | FILIP1L | filamin A interacting protein 1-like |
71 | 6303 | 7.9 | 9.2 | 0.4 | 0.8 | 2.437 | 0.0899 | SAT1 | spermidine/spermine N1-acetyltransferase 1 |
72 | 272 | 3.2 | 3.0 | 0.7 | 0.4 | -0.287 | 0.7918 | AMPD3 | adenosine monophosphate deaminase 3 |
73 | 10135 | 8.8 | 9.8 | 0.2 | 0.0 | 10.018 | 0.0056 | NAMPT | nicotinamide phosphoribosyltransferase |
74 | 5966 | 9.0 | 8.6 | 0.1 | 0.5 | -1.634 | 0.2363 | REL | v-rel avian reticuloendotheliosis viral oncogene homolog |
75 | 3553 | 2.4 | 2.3 | 0.1 | 0.0 | -1.410 | 0.2319 | IL1B | interleukin 1, beta |
76 | 374 | 6.2 | 12.7 | 0.4 | 0.9 | 12.056 | 0.0017 | AREG | amphiregulin |
77 | 1545 | 10.2 | 11.3 | 0.1 | 0.2 | 6.811 | 0.0043 | CYP1B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 |
78 | 7832 | 12.2 | 10.1 | 0.3 | 0.2 | -10.744 | 0.0005 | BTG2 | BTG family, member 2 |
79 | 694 | 10.6 | 9.8 | 0.1 | 0.6 | -2.225 | 0.1537 | BTG1 | B-cell translocation gene 1, anti-proliferative |
80 | 9308 | 7.4 | 7.3 | 0.1 | 0.7 | -0.104 | 0.9266 | CD83 | CD83 molecule |
81 | 5806 | 2.4 | 3.4 | 0.0 | 1.0 | 1.800 | 0.2133 | PTX3 | pentraxin 3, long |
82 | 942 | 8.0 | 7.6 | 0.3 | 0.1 | -2.296 | 0.1215 | CD86 | CD86 molecule |
83 | 4790 | 10.2 | 10.6 | 0.0 | 0.1 | 5.908 | 0.0248 | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
84 | 4791 | 6.8 | 6.9 | 0.8 | 0.2 | 0.158 | 0.8877 | NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
85 | 2495 | 16.6 | 17.1 | 0.3 | 0.2 | 2.412 | 0.0877 | FTH1 | ferritin, heavy polypeptide 1 |
86 | 723790 | 11.0 | 10.4 | 0.2 | 0.2 | -3.100 | 0.0362 | HIST2H2AA4 | histone cluster 2, H2aa4 |
87 | 969 | 2.6 | 2.5 | 0.3 | 0.4 | -0.245 | 0.8197 | CD69 | CD69 molecule |
88 | 729540 | 7.6 | 7.8 | 0.1 | 0.4 | 0.634 | 0.5803 | RGPD6 | RANBP2-like and GRIP domain containing 6 |
89 | 84220 | 10.1 | 10.2 | 0.1 | 0.2 | 1.017 | 0.4024 | RGPD5 | RANBP2-like and GRIP domain containing 5 |
90 | 6446 | 7.0 | 8.8 | 0.5 | 0.1 | 6.735 | 0.0126 | SGK1 | serum/glucocorticoid regulated kinase 1 |
91 | 2537 | 8.7 | 14.5 | 1.0 | 1.2 | 6.286 | 0.0037 | IFI6 | interferon, alpha-inducible protein 6 |
92 | 3398 | 12.0 | 12.0 | 0.5 | 0.4 | 0.165 | 0.8773 | ID2 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
93 | 23645 | 6.9 | 8.0 | 0.4 | 0.5 | 2.901 | 0.0445 | PPP1R15A | protein phosphatase 1, regulatory subunit 15A |
94 | 6696 | 2.4 | 2.6 | 0.2 | 0.3 | 0.917 | 0.4305 | SPP1 | secreted phosphoprotein 1 |
95 | 19 | 3.0 | 2.5 | 0.6 | 0.2 | -1.380 | 0.2854 | ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 |
96 | 10105 | 13.9 | 13.9 | 0.1 | 0.4 | -0.106 | 0.9242 | PPIF | peptidylprolyl isomerase F |
97 | 4170 | 10.3 | 10.5 | 0.4 | 0.0 | 0.927 | 0.4495 | MCL1 | myeloid cell leukemia 1 |
98 | 57018 | 11.1 | 10.7 | 0.1 | 0.2 | -2.815 | 0.0836 | CCNL1 | cyclin L1 |
99 | 64135 | 9.2 | 11.1 | 0.2 | 0.4 | 7.401 | 0.0056 | IFIH1 | interferon induced with helicase C domain 1 |
100 | 7130 | 2.3 | 2.7 | 0.0 | 0.8 | 0.986 | 0.4277 | TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 |
101 | 51561 | 7.2 | 7.9 | 0.1 | 0.5 | 2.418 | 0.1211 | IL23A | interleukin 23, alpha subunit p19 |
102 | 5329 | 3.9 | 4.7 | 0.2 | 1.4 | 0.958 | 0.4353 | PLAUR | plasminogen activator, urokinase receptor |
103 | 965 | 7.9 | 8.6 | 0.3 | 0.3 | 2.378 | 0.0771 | CD58 | CD58 molecule |
104 | 3726 | 7.3 | 7.5 | 0.4 | 0.4 | 0.470 | 0.6628 | JUNB | jun B proto-oncogene |
105 | 1983 | 8.4 | 9.2 | 0.3 | 0.2 | 3.856 | 0.0190 | EIF5 | eukaryotic translation initiation factor 5 |
106 | 8336 | 12.6 | 12.9 | 0.0 | 0.0 | 8.718 | 0.0061 | HIST1H2AM | histone cluster 1, H2am |
107 | 8332 | 7.0 | 8.6 | 0.1 | 0.3 | 10.033 | 0.0069 | HIST1H2AL | histone cluster 1, H2al |
108 | 8329 | 8.7 | 9.3 | 0.2 | 0.1 | 5.344 | 0.0159 | HIST1H2AI | histone cluster 1, H2ai |
109 | 85235 | 13.7 | 13.9 | 0.1 | 0.2 | 1.586 | 0.2240 | HIST1H2AH | histone cluster 1, H2ah |
110 | 8330 | 14.7 | 14.7 | 0.0 | 0.1 | 0.809 | 0.4956 | HIST1H2AK | histone cluster 1, H2ak |
111 | 8331 | 15.0 | 15.2 | 0.0 | 0.2 | 1.504 | 0.2694 | HIST1H2AJ | histone cluster 1, H2aj |
112 | 3013 | 13.5 | 13.1 | 0.1 | 0.2 | -3.379 | 0.0561 | HIST1H2AD | histone cluster 1, H2ad |
113 | 8969 | 4.8 | 4.7 | 0.7 | 1.7 | -0.129 | 0.9067 | HIST1H2AG | histone cluster 1, H2ag |
114 | 8942 | 6.9 | 10.6 | 0.4 | 0.1 | 15.658 | 0.0033 | KYNU | kynureninase |
115 | 23710 | 6.6 | 5.6 | 0.6 | 0.2 | -2.450 | 0.1132 | GABARAPL1 | GABA(A) receptor-associated protein like 1 |
116 | 4929 | 6.0 | 6.8 | 0.1 | 0.0 | 18.498 | 0.0001 | NR4A2 | nuclear receptor subfamily 4, group A, member 2 |
117 | 8013 | 4.3 | 3.6 | 0.5 | 0.4 | -1.930 | 0.1280 | NR4A3 | nuclear receptor subfamily 4, group A, member 3 |
118 | 8358 | 13.5 | 13.5 | 0.1 | 0.1 | 0.176 | 0.8723 | HIST1H3B | histone cluster 1, H3b |
119 | 8352 | 14.1 | 15.1 | 0.2 | 0.5 | 3.104 | 0.0742 | HIST1H3C | histone cluster 1, H3c |
120 | 8350 | 13.6 | 13.1 | 0.2 | 0.2 | -3.950 | 0.0170 | HIST1H3A | histone cluster 1, H3a |
121 | 8968 | 12.4 | 12.7 | 0.0 | 0.2 | 2.693 | 0.1087 | HIST1H3F | histone cluster 1, H3f |
122 | 8355 | 13.1 | 13.6 | 0.0 | 0.2 | 5.811 | 0.0203 | HIST1H3G | histone cluster 1, H3g |
123 | 8351 | 13.7 | 13.9 | 0.0 | 0.2 | 1.524 | 0.2542 | HIST1H3D | histone cluster 1, H3d |
124 | 8353 | 12.6 | 12.4 | 0.1 | 0.1 | -1.773 | 0.1511 | HIST1H3E | histone cluster 1, H3e |
125 | 8356 | 9.0 | 9.5 | 0.5 | 0.3 | 1.479 | 0.2258 | HIST1H3J | histone cluster 1, H3j |
126 | 8357 | 9.7 | 10.0 | 0.1 | 0.1 | 3.279 | 0.0306 | HIST1H3H | histone cluster 1, H3h |
127 | 8354 | 9.1 | 9.8 | 0.1 | 0.1 | 9.407 | 0.0010 | HIST1H3I | histone cluster 1, H3i |
128 | 8878 | 13.2 | 12.9 | 0.4 | 0.1 | -1.232 | 0.3257 | SQSTM1 | sequestosome 1 |
129 | 10561 | 5.0 | 11.8 | 0.1 | 1.1 | 10.601 | 0.0079 | IFI44 | interferon-induced protein 44 |
130 | 4973 | 2.4 | 2.3 | 0.0 | 0.1 | -1.379 | 0.2478 | OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 |
131 | 834 | 2.2 | 3.0 | 0.0 | 1.3 | 0.987 | 0.4276 | CASP1 | caspase 1, apoptosis-related cysteine peptidase |
132 | 9638 | 8.6 | 8.4 | 0.1 | 0.8 | -0.286 | 0.8006 | FEZ1 | fasciculation and elongation protein zeta 1 (zygin I) |
133 | 8870 | 14.3 | 12.8 | 0.2 | 0.2 | -11.073 | 0.0004 | IER3 | immediate early response 3 |
134 | 1959 | 3.3 | 3.1 | 0.6 | 0.5 | -0.366 | 0.7328 | EGR2 | early growth response 2 |
135 | 467 | 6.5 | 7.7 | 0.2 | 0.9 | 2.324 | 0.1342 | ATF3 | activating transcription factor 3 |
136 | 604 | 10.7 | 11.2 | 0.2 | 0.9 | 0.780 | 0.5119 | BCL6 | B-cell CLL/lymphoma 6 |
137 | 602 | 12.8 | 12.3 | 0.1 | 0.2 | -4.759 | 0.0115 | BCL3 | B-cell CLL/lymphoma 3 |